integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | |
---|---|
Identifiers | |
Symbol | ITGA2B |
Alt. symbols | GP2B |
Entrez | 3674 |
HUGO | 6138 |
OMIM | 607759 |
RefSeq | NM_000419 |
UniProt | P08514 |
Other data | |
Locus | Chr. 17 q21.32 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | |
---|---|
Identifiers | |
Symbol | ITGB3 |
Alt. symbols | GP3A |
Entrez | 3690 |
HUGO | 6156 |
OMIM | 173470 |
RefSeq | NM_000212 |
UniProt | P05106 |
Other data | |
Locus | Chr. 17 q21.32 |
In medicine, glycoprotein IIb/IIIa (gpIIb/IIIa, also known as integrin αIIbβ3) is an integrin complex found on platelets. It is a receptor for fibrinogen and aids in platelet activation. The complex is formed via calcium-dependent association of gpIIb and gpIIIa, a required step in normal platelet aggregation and endothelial adherence.[1][2] Platelet activation by ADP (blocked by clopidogrel) leads to a conformational change in platelet gpIIb/IIIa receptors that induces binding to fibrinogen. The gpIIb/IIIa receptor is a target of several drugs including abciximab, eptifibatide, tirofiban.
Contents |
Defects in glycoprotein IIb/IIIa cause Glanzmann's thrombasthenia.[3]
Autoantibodies against IIb/IIIa can be produced in immune thrombocytopenic purpura.[4]
Glycoprotein IIb/IIIa inhibitors can be used to prevent blood clots in an effort to decrease the risk of heart attack or stroke.
|
|
|